Platelets could be an ideal target for gene therapy of hemophilia A as they can store neoprotein FVIII together with its carrier protein von Willebrand factor (VWF) in α-granules and act as delivery vehicles in blood circulation. The gene discussed is VWF; the disease is hemophilia A.